The new Veterinary Medicines Regulation: rising to the challenge
|Title:||The new Veterinary Medicines Regulation: rising to the challenge||Authors:||More, Simon John; McCoy, Finola; McAloon, Catherine I.||Permanent link:||http://hdl.handle.net/10197/13107||Date:||3-Feb-2022||Online since:||2022-08-30T10:41:17Z||Abstract:||This article focuses on the new Veterinary Medicines Regulation, which is applicable across all Member States of the European Union, including Ireland, from 28 January 2022. From this date, prophylactic use of antimicrobials (AMs) in groups of animals is banned, metaphylactic use in groups of animals is restricted, and certain AMs are reserved for humans only. In the Irish dairy industry, as elsewhere, successful implementation of the Regulation will require a high level of mastitis control across all herds, and measures to support high standards in antibiotic stewardship. National actions will be critical, to support optimal mastitis control throughout the national herd. For private veterinary practitioners (PVPs), the Regulation will lead to specific prescribing changes, including the requirement to shift from blanket to selective dry cow therapy. Further, prescribing choices will need to be guided by the categorisation for AMs developed by the European Medicines Agency (EMA). More broadly, the Regulation requires a fundamental shift in thinking both in terms of AM usage and of the role of the PVP. Given the close association between mastitis control and intramammary AM stewardship, it is imperative that prescribing and mastitis control decisions are made concurrently. A herd health approach will be critical, within a Client-Patient-Practice Relationship as outlined by the Veterinary Council of Ireland. On those farms with sub-optimal mastitis control, mastitis issues need to be sustainably resolved. A detailed farm investigation by the PVP, in partnership with the farmer and other milk quality professionals, is essential, to understand the epidemiology and on-farm drivers of mastitis, to develop farm-specific action plans, and to facilitate ongoing monitoring of progress. It is vital that PVPs provide leadership, with the provision of a holistic, herd health approach to inform both prescribing and mastitis control decisions in herds under their care.||Type of material:||Journal Article||Publisher:||Springer||Journal:||Irish Veterinary Journal||Volume:||75||Issue:||1||Copyright (published version):||2022 the Authors||Keywords:||Veterinary Medicines Regulation; Regulation (EU) 2019/6; Intramammary antimicrobials; Antimicrobial stewardship; Mastitis control; Private veterinary practitioners; Ireland||DOI:||10.1186/s13620-022-00209-6||Language:||en||Status of Item:||Peer reviewed||This item is made available under a Creative Commons License:||https://creativecommons.org/licenses/by/3.0/ie/|
|Appears in Collections:||Veterinary Medicine Research Collection|
CVERA Research Collection
Show full item record
If you are a publisher or author and have copyright concerns for any item, please email firstname.lastname@example.org and the item will be withdrawn immediately. The author or person responsible for depositing the article will be contacted within one business day.